StockData
ProKidney Corp. logo

ProKidney Corp. (PROK) stock

PROKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.04−0.06 (-5.45%)

Close on Nov 18, 2026Market cap $314.42MP/E –Yield –

ProKidney net income

Net income is the profit left for shareholders after every expense, interest and tax.

ProKidney's net income for the twelve months ending Jun 30, 2026 was -$84.16M. For fiscal 2025 it was -$68.99M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$68.99M–
FY2024Dec 31, 2024-$61.19M–
FY2023Dec 31, 2023-$35.47M–
FY2021Dec 31, 2021-$55.15M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$28.42M–
Q1 FY2026Mar 31, 2026-$20.04M–
Q4 FY2025Dec 31, 2025-$19.23M–
Q3 FY2025Sep 30, 2025-$16.47M–
Q2 FY2025Jun 30, 2025-$16.55M–
Q1 FY2025Mar 31, 2025-$16.73M–
Q4 FY2024Dec 31, 2024-$21.28M–
Q3 FY2024Sep 30, 2024-$17.91M–
Q2 FY2024Jun 30, 2024-$12.51M–
Q1 FY2024Mar 31, 2024-$9.49M–
Q4 FY2023Dec 31, 2023-$5.70M–
Q3 FY2023Sep 30, 2023-$10.98M–
Q2 FY2023Jun 30, 2023-$9.12M–
Q1 FY2023Mar 31, 2023-$9.67M–
Q3 FY2022Sep 30, 2022-$29.93M–
Q2 FY2022Jun 30, 2022-$2.27M–
Q1 FY2022Mar 31, 2022-$3.98M–
Q3 FY2021Sep 30, 2021-$252.49K–
Q2 FY2021Jun 30, 2021-$143–

More ProKidney figures

See a number that looks wrong?